...
首页> 外文期刊>Current Drug Delivery >Self Micro-Emulsifying Drug Delivery System: Formulation Development and Biopharmaceutical Evaluation of Lipophilic Drugs
【24h】

Self Micro-Emulsifying Drug Delivery System: Formulation Development and Biopharmaceutical Evaluation of Lipophilic Drugs

机译:自身微乳化药物递送系统:亲脂性药物的配方开发和生物制药评价

获取原文
获取原文并翻译 | 示例

摘要

Several methods are being employed to improve the oral bioavailability of lipophilic drugs like using inert lipid vehicles such as Oils, Surfactant dispersions, Self Microemulsifying Drug Delivery Systems (SMEDDS) and Liposomes. SMEDDS is formulated with the help of oil or suitable lipid materials, Surfactants and hydrophilic Co-surfactants. Mixture of above ingredients can be filled in a soft capsule and ingested. When the mixture comes in contact with gastrointestinal fluid it forms a stable O/W Microemulsion. A pseudo ternary phase diagram is used for identifying the efficient Self micro-emulsification region. SMEDDS can be formulated to give sustained release by use of inert polymers. When this polymer comes in contact with GI fluids, it forms gelled polymeric matrix, which releases the micro-emulsified active principle in a continuous and prolonged manner. Physical characterization of SMEDDS should be carried out by droplet size analysis and spontaneity of emulsification. The purpose of this review is to provide a brief out line of the formulation of SMEDDS, possible mode for improving bioavailability, fate and evaluation of the same.
机译:已采用几种方法来改善亲脂性药物的口服生物利用度,例如使用惰性脂质载体,如油,表面活性剂分散液,自微乳化药物递送系统(SMEDDS)和脂质体。 SMEDDS是在油或合适的脂质材料,表面活性剂和亲水性辅助表面活性剂的帮助下配制的。可以将上述成分的混合物装入软胶囊中并摄取。当混合物与胃肠道液体接触时,它会形成稳定的O / W微乳液。伪三元相图用于识别有效的自微乳化区域。 SMEDDS可以配制成通过使用惰性聚合物来持续释放。当这种聚合物与GI液体接触时,它会形成凝胶状的聚合物基质,该基质会持续且长时间释放微乳化的活性成分。 SMEDDS的物理表征应通过液滴大小分析和乳化的自发性进行。这篇综述的目的是简要介绍SMEDDS的配方,改善生物利用度的可能模式,命运及其评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号